Tien Liang Biotech Co

Tien Liang Biotech Co FCF per Share

The Free Cash Flow per Share of Tien Liang Biotech Co (4127.TWO) as of Nov 19, 2026 is -0.09 TWD. In the previous year, Free Cash Flow per Share was 0.95 TWD — a change of -109.26% (lower).

FCF per Share

-0.09TWD

YoY

-109.26%

Last updated:

Free Cash Flow per Share of Tien Liang Biotech Co is 2025 -0.09 TWD. Free Cash Flow per Share of Tien Liang Biotech Co was 2024 0.95 TWD. It decreases by -109.26% lower compared to the previous year.

The Tien Liang Biotech Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
-2.50 TWD
Jan 1, 2018
-0.56 TWD
Jan 1, 2020
-0.26 TWD
Jan 1, 2021
0.95 TWD
Jan 1, 2022
0.46 TWD
Jan 1, 2023
1.43 TWD
Jan 1, 2024
0.95 TWD
Jan 1, 2025
-0.09 TWD
The Tien Liang Biotech Co FCF per Share history
YEARFCF per ShareYoY
-0.09TWD-109.26%
0.95TWD-33.70%
1.43TWD+213.28%
0.46TWD-52.30%
0.95TWD-462.26%
-0.26TWD-52.61%
-0.56TWD-77.80%
-2.50TWD+95.56%
-1.28TWD-196.61%
1.33TWD+63.84%
0.81TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tien Liang Biotech Co Stock analysis

What does Tien Liang Biotech Co do? Tien Liang BioTech Co. Ltd. manufactures and sells Chinese herbal and western medicine, including active pharmaceutical ingredients (APIs), biopharmaceuticals, and traditional Chinese medicines. The company imports, wholesales, and retails western medicines domestically. Its products are distributed within the domestic market, targeting healthcare providers and consumers seeking traditional and modern pharmaceutical solutions. The firm's revenue streams come from the sale of manufactured medicines, APIs, biopharmaceuticals, and retail distribution of western medicines. Domestic market sales form the core of its business, with no mention of international distribution channels. The company serves both the traditional Chinese medicine segment and the modern pharmaceutical segment through its comprehensive product portfolio. Tien Liang BioTech operates within the pharmaceutical manufacturing and distribution sector, focusing on domestic sales of herbal, western, and biopharmaceutical products. Its business model integrates manufacturing, import, wholesale, and retail operations to serve the local healthcare market. Tien Liang Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tien Liang Biotech Co stock

Free Cash Flow per Share of Tien Liang Biotech Co is -0.09 TWD in 2025.

Free Cash Flow per Share of Tien Liang Biotech Co changed from 0.95 TWD to -0.09 TWD, representing a -109.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Tien Liang Biotech Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Tien Liang Biotech Co

All Key Metrics — Tien Liang Biotech Co